CAIXABANK MULTISALUD, FI
•PLUS
Cartera Renta Variable
| 2024-Q2 | ||||
|---|---|---|---|---|
1 | ELI LILLY AND CO | 57.551.772 € | 7.39% | 61% |
2 | 第一三共株式会社 | 53.275.169 € | 6.84% | 1.35% |
3 | ASTRAZENECA PLC | 41.919.202 € | 5.38% | 124.62% |
4 | LONZA GROUP LTD | 37.302.591 € | 4.79% | 0.04% |
5 | JOHNSON & JOHNSON | 35.745.406 € | 4.59% | 5.4% |
6 | GILEAD SCIENCES INC | 34.601.514 € | 4.44% | 47.6% |
7 | NOVO NORDISK AS CLASS B | 31.493.770 € | 4.04% | 48.72% |
8 | UNITEDHEALTH GROUP INC | 27.810.322 € | 3.57% | 35.07% |
9 | MERCK & CO INC | 26.965.769 € | 3.46% | 16.2% |
10 | BAXTER INTERNATIONAL INC | 24.937.723 € | 3.2% | 2.63% |
11 | ROCHE HOLDING AG | 23.279.584 € | 2.99% | Nueva |
12 | EDWARDS LIFESCIENCES CORP | 21.378.338 € | 2.75% | 4.66% |
13 | ALMIRALL SA | 21.150.000 € | 2.72% | 11.57% |
14 | エーザイ株式会社 | 20.018.133 € | 2.57% | 19.42% |
15 | CENTENE CORP | 19.970.531 € | 2.56% | 442.94% |
16 | THERMO FISHER SCIENTIFIC INC | 18.679.949 € | 2.4% | 19.56% |
17 | BIOGEN INC | 17.563.433 € | 2.26% | 318.94% |
18 | 中外製薬株式会社 | 16.328.106 € | 2.1% | 153.79% |
19 | BAYER AG | 14.231.535 € | 1.83% | Nueva |
20 | 大塚ホールディングス株式会社 | 13.672.992 € | 1.76% | 47.61% |
21 | THE CIGNA GROUP | 12.469.134 € | 1.6% | Nueva |
22 | ABBVIE INC | 11.450.093 € | 1.47% | 21.89% |
23 | SARTORIUS STEDIM BIOTECH SA | 10.715.823 € | 1.38% | 45.09% |
24 | TELEFLEX INC | 10.452.484 € | 1.34% | 36.71% |
25 | CONVATEC GROUP PLC | 10.251.284 € | 1.32% | 45.35% |
26 | ALNYLAM PHARMACEUTICALS INC | 9.560.511 € | 1.23% | Nueva |
27 | ABBOTT LABORATORIES | 9.538.455 € | 1.23% | 290.27% |
28 | BACHEM HOLDING AG | 8.991.743 € | 1.15% | 22.63% |
29 | ZIMMER BIOMET HOLDINGS INC | 8.507.917 € | 1.09% | 66.67% |
30 | CENCORA INC | 7.867.726 € | 1.01% | 52.14% |
31 | HIKMA PHARMACEUTICALS PLC | 7.783.840 € | 1% | 5.66% |
32 | HUMANA INC | 7.199.155 € | 0.92% | 59.65% |
33 | MEDTRONIC PLC | 6.788.710 € | 0.87% | 61.24% |
34 | NOVARTIS AG REGISTERED SHARES | 5.992.646 € | 0.77% | Nueva |
35 | IONIS PHARMACEUTICALS INC | 4.326.332 € | 0.56% | Nueva |
36 | COLOPLAST AS CLASS B | 3.836.249 € | 0.49% | 120.07% |
37 | MERCK KGAA | 2.575.040 € | 0.33% | 7.39% |
38 | BECTON DICKINSON & CO | 2.049.299 € | 0.26% | Nueva |
39 | SARTORIUS AG VORZ-INHABER-AKT OHNE STIMMRECHT | 683.937 € | 0.09% | 39.16% |
| 2024-Q4 | ||||
|---|---|---|---|---|
1 | NOVO NORDISK AS CLASS B | 47.997.041 € | 6.97% | 52.4% |
2 | ELI LILLY AND CO | 44.982.219 € | 6.53% | 21.84% |
3 | ASTRAZENECA PLC | 42.687.407 € | 6.2% | 1.83% |
4 | JOHNSON & JOHNSON | 37.824.444 € | 5.49% | 5.82% |
5 | BAXTER INTERNATIONAL INC | 33.570.469 € | 4.88% | 34.62% |
6 | MERCK & CO INC | 33.175.526 € | 4.82% | 23.03% |
7 | 第一三共株式会社 | 32.614.589 € | 4.74% | 38.78% |
8 | ABBVIE INC | 26.889.080 € | 3.91% | 134.84% |
9 | ROCHE HOLDING AG | 26.635.050 € | 3.87% | 14.41% |
10 | LONZA GROUP LTD | 25.363.651 € | 3.68% | 32.01% |
11 | UNITEDHEALTH GROUP INC | 24.441.069 € | 3.55% | 12.12% |
12 | CENCORA INC | 24.213.643 € | 3.52% | 207.76% |
13 | THERMO FISHER SCIENTIFIC INC | 22.332.449 € | 3.24% | 19.55% |
14 | HUMANA INC | 20.764.125 € | 3.02% | 188.42% |
15 | IDEXX LABORATORIES INC | 17.011.768 € | 2.47% | Nueva |
16 | DEXCOM INC | 16.594.587 € | 2.41% | Nueva |
17 | ALMIRALL SA | 16.470.000 € | 2.39% | 22.13% |
18 | ALIGN TECHNOLOGY INC | 14.429.935 € | 2.1% | Nueva |
19 | SARTORIUS STEDIM BIOTECH SA | 13.190.319 € | 1.92% | 23.09% |
20 | ELEVANCE HEALTH INC | 10.355.269 € | 1.5% | Nueva |
21 | TELEFLEX INC | 9.924.165 € | 1.44% | 5.05% |
22 | ZIMMER BIOMET HOLDINGS INC | 9.600.261 € | 1.39% | 12.84% |
23 | エムスリー株式会社 | 8.841.370 € | 1.28% | Nueva |
24 | MEDTRONIC PLC | 8.344.350 € | 1.21% | 22.92% |
25 | BIO-TECHNE CORP | 7.964.640 € | 1.16% | Nueva |
26 | CHARLES RIVER LABORATORIES INTERNATIONAL INC | 7.743.452 € | 1.12% | Nueva |
27 | HIKMA PHARMACEUTICALS PLC | 6.863.447 € | 1% | 11.82% |
28 | BACHEM HOLDING AG | 6.478.857 € | 0.94% | 27.95% |
29 | NOVARTIS AG REGISTERED SHARES | 4.955.464 € | 0.72% | 17.31% |
30 | ＨＯＹＡ株式会社 | 4.250.421 € | 0.62% | Nueva |
31 | BECTON DICKINSON & CO | 4.135.940 € | 0.6% | 101.82% |
32 | IONIS PHARMACEUTICALS INC | 3.281.485 € | 0.48% | 24.15% |
33 | ALNYLAM PHARMACEUTICALS INC | 3.114.220 € | 0.45% | 67.43% |
34 | GILEAD SCIENCES INC | 2.879.757 € | 0.42% | 91.68% |
35 | ABBOTT LABORATORIES | 2.635.211 € | 0.38% | 72.37% |
36 | MERCK KGAA | 2.327.936 € | 0.34% | 9.6% |
37 | CONVATEC GROUP PLC | 1.618.638 € | 0.24% | 84.21% |
38 | CENTENE CORP | 986.965 € | 0.14% | 95.06% |
39 | ROCHE HOLDING AG BEARER SHARES | 911.843 € | 0.13% | Nueva |
40 | SARTORIUS AG VORZ-INHABER-AKT OHNE STIMMRECHT | 672.070 € | 0.1% | 1.74% |
41 | BIOGEN INC | 0 € | Vendida | |
42 | EDWARDS LIFESCIENCES CORP | 0 € | Vendida | |
43 | BAYER AG | 0 € | Vendida | |
44 | エーザイ株式会社 | 0 € | Vendida | |
45 | THE CIGNA GROUP | 0 € | Vendida | |
46 | COLOPLAST AS CLASS B | 0 € | Vendida | |
47 | 中外製薬株式会社 | 0 € | Vendida | |
48 | 大塚ホールディングス株式会社 | 0 € | Vendida | |